Filing Details
- Accession Number:
- 0000899243-21-003114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-22 21:36:27
- Reporting Period:
- 2021-01-21
- Accepted Time:
- 2021-01-22 21:36:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1627766 | E Sean George | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-21 | 5,000 | $8.70 | 646,018 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-21 | 7,003 | $53.60 | 639,015 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-21 | 1,272 | $54.27 | 637,743 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-21 | 400 | $55.69 | 637,343 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2021-01-21 | 5,000 | $0.00 | 5,000 | $8.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,000 | 2024-10-15 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 282,848 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $53.02 to $53.99 per share.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $54.03 to $54.77 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $55.46 to $55.89 per share.
- The shares subject to this option are fully vested and exercisable.
Billionaire Hedge Funds
